These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 16105242

  • 21. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM.
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [Abstract] [Full Text] [Related]

  • 24. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Auton Neurosci; 2003 Mar 28; 104(2):88-94. PubMed ID: 12648610
    [Abstract] [Full Text] [Related]

  • 25. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J, Jia R, Bao Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 28; 8(3):118-26. PubMed ID: 17907099
    [Abstract] [Full Text] [Related]

  • 26. [Two-week administration of low-dose Hachimi-jio-gan (Ba-Wei Di-Huang-Wan) for patients with benign prostatic hyperplasia].
    Yoshimura K, Terai A, Arai Y.
    Hinyokika Kiyo; 2003 Sep 28; 49(9):509-14. PubMed ID: 14598687
    [Abstract] [Full Text] [Related]

  • 27. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Horm Metab Res; 2001 Nov 28; 33(11):664-9. PubMed ID: 11733869
    [Abstract] [Full Text] [Related]

  • 28. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol.
    Kuhad A, Sachdeva AK, Chopra K.
    J Agric Food Chem; 2009 Jul 22; 57(14):6123-8. PubMed ID: 19601660
    [Abstract] [Full Text] [Related]

  • 29. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.
    Exp Clin Endocrinol Diabetes; 2007 Oct 22; 115(9):571-6. PubMed ID: 17943690
    [Abstract] [Full Text] [Related]

  • 30. The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats.
    Stefek M, Gajdosik A, Tribulova N, Navarova J, Volkovova K, Weismann P, Gajdosikova A, Drimal J, Mihalova D.
    Methods Find Exp Clin Pharmacol; 2002 Nov 22; 24(9):565-71. PubMed ID: 12616702
    [Abstract] [Full Text] [Related]

  • 31. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats.
    Kumarappan CT, Mandal SC.
    Ren Fail; 2008 Nov 22; 30(3):307-22. PubMed ID: 18350451
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S, Mahadevan N, Balakumar P.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):388-96. PubMed ID: 23085026
    [Abstract] [Full Text] [Related]

  • 33. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.
    Clin Exp Pharmacol Physiol; 2006 Jan 05; 33(1-2):95-101. PubMed ID: 16445706
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Sohn EJ, Kim CS, Kim YS, Jung DH, Jang DS, Lee YM, Kim JS.
    Life Sci; 2007 Jan 09; 80(5):468-75. PubMed ID: 17070554
    [Abstract] [Full Text] [Related]

  • 36. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.
    Chen LL, Zhang JY, Wang BP.
    Vascul Pharmacol; 2006 May 09; 44(5):309-15. PubMed ID: 16624630
    [Abstract] [Full Text] [Related]

  • 37. Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats.
    Yamabe N, Kang KS, Matsuo Y, Tanaka T, Yokozawa T.
    Biol Pharm Bull; 2007 Jul 09; 30(7):1289-96. PubMed ID: 17603169
    [Abstract] [Full Text] [Related]

  • 38. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK, Reddy K, Balakumar P.
    Eur J Pharmacol; 2010 Jun 25; 636(1-3):137-44. PubMed ID: 20347778
    [Abstract] [Full Text] [Related]

  • 39. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
    Lee SH, Kim YS, Lee SJ, Lee BC.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1409-14. PubMed ID: 21856399
    [Abstract] [Full Text] [Related]

  • 40. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
    Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ.
    J Ethnopharmacol; 2011 Dec 08; 138(3):731-6. PubMed ID: 22027446
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.